Published
Video duration:
1 minute
Business: Novo Nordisk will invest more than two billion euros in Chartres
In Chartres, in Eure-et-Loir, the investment of the pharmaceutical giant Novo Nordisk delights the residents, who hope for economic benefits. – (France 2)
In Chartres, in Eure-et-Loir, the investment of the pharmaceutical giant Novo Nordisk delights the residents, who hope for economic benefits.
In Chartres (Eure-et-Loir), the pharmaceutical giant Novo Nordisk, which produces treatments against diabetes, will invest more than two billion euros in its factory. A boon for the residents. “Whether it’s in terms of employment for the region, it’s super cool,” assures a man. City professionals expect economic benefits with the creation of more than 500 new jobs.
Largest private employer in the department
A real estate agent is also hoping for a boost in activity. Novo Nordisk, established in the city for more than 60 years, is the largest private employer in the department, with 1,600 employees. “At the site level, that means more dynamism and more production also for our patients, more treatments”, rejoices Pauline Amiet, employee of the group. This new investment is the largest in recent years in France in the health sector.
